Redmile Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $83.3M | Buy |
|
|||||
|
2023
Q4 | $77.4M | Buy |
|
|||||
|
2023
Q3 | $56.9M | Sell |
|
|||||
|
2023
Q2 | $68.7M | Sell |
|
|||||
|
2023
Q1 | $86.2M | Buy |
|
|||||
|
2022
Q4 | $58.9M | Buy |
|
|||||
|
2022
Q3 | $55M | Buy |
|
|||||
|
2022
Q2 | $18.8M | Buy |
|
|||||
|
2022
Q1 | $6.16M | Hold |
|
|||||
|
2021
Q4 | $6.5M | Sell |
|
|||||
|
2021
Q3 | $137M | Sell |
|
|||||
|
2021
Q2 | $155M | Sell |
|
|||||
|
2021
Q1 | $195M | Sell |
|
|||||
|
2020
Q4 | $253M | Sell |
|
|||||
|
2020
Q3 | $245M | Sell |
|
|||||
|
2020
Q2 | $297M | Sell |
|
|||||
|
2020
Q1 | $211M | Buy |
|
|||||
|
2019
Q4 | $293M | Sell |
|
|||||
|
2019
Q3 | $162M | Buy |
|
|||||
|
2019
Q2 | $50.1M | Buy |
|
|||||
|
2019
Q1 | $37.8M | Sell |
|
|||||
|
2018
Q4 | $34.7M | Buy |
|
|||||
|
2018
Q3 | $57.2M | Sell |
|
|||||
|
2018
Q2 | $58.1M | Buy |
|
|||||
|
2018
Q1 | $16.5M | Buy |
|
|||||
|
2017
Q4 | $14.7M | Sell |
|
|||||
|
2017
Q3 | $12M | Buy |
|